Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Virologic and immunologic effectiveness of tipranavir/ritonavir (TPV/r)- versus darunavir/ritonavir (DRV/r)-based regimens in clinical practice.
Antoniou T, Raboud JM, Diong C, Su D, Dewhurst N, Buckley V, Kovacs C, Rachlis A, Brunetta J, Smith G, Gough K, Fletcher D, Loutfy MR. Antoniou T, et al. Among authors: fletcher d. J Int Assoc Physicians AIDS Care (Chic). 2010 Nov-Dec;9(6):382-9. doi: 10.1177/1545109710382041. J Int Assoc Physicians AIDS Care (Chic). 2010. PMID: 21138833
Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral Regimens.
Varriano B, Crouzat F, Sandler I, Smith G, Kovacs C, Gupta M, Brunetta J, Fletcher D, Knox D, Merkley B, Chang B, Tilley D, Acsai M, Loutfy M. Varriano B, et al. Among authors: fletcher d. AIDS Res Hum Retroviruses. 2021 Jan;37(1):44-53. doi: 10.1089/AID.2020.0053. Epub 2020 Nov 2. AIDS Res Hum Retroviruses. 2021. PMID: 33019803
Changes in renal and metabolic indices after switching from tenofovir disoproxil fumarate- to tenofovir alafenamide-containing ART among individuals with HIV in Canada: A retrospective study.
Shokoohi M, Gupta M, Crouzat F, Smith G, Kovacs C, Brunetta J, Chang B, Knox D, Acsai M, Merkley B, Giolma K, Fletcher D, Loutfy M. Shokoohi M, et al. Among authors: fletcher d. Int J STD AIDS. 2021 Aug;32(9):861-871. doi: 10.1177/0956462421999931. Epub 2021 Apr 23. Int J STD AIDS. 2021. PMID: 33890817
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-).
Antoniou T, Smith G, Su D, Raboud JM, Lee D, Kovacs C, Brunetta J, Fletcher D, Crouzat F, Loutfy M. Antoniou T, et al. Among authors: fletcher d. J Int Assoc Physicians AIDS Care (Chic). 2012 May-Jun;11(3):192-7. doi: 10.1177/1545109711424967. Epub 2012 Jan 13. J Int Assoc Physicians AIDS Care (Chic). 2012. PMID: 22247337
1,213 results